-
Review your patient charts for the past month. If national statistics are any indication, chances are many of those cases include a diagnosis of urinary tract infection (UTI).
-
-
Use of the cervical cancer vaccine may soon expand: Merck has filed with the Food and Drug Administration (FDA) for use of Gardasil (Merck & Co.; Whitehouse Station, NJ) in use in women ages 27 through 45.
-
Your next patient is a healthy, fit 45-year-old nonsmoking woman. She says her menstrual periods are now less regular, and she reports having intermittent hot flashes. Newly divorced, she is now sexually active and wonders which contraceptive is right for her. What's your recommendation?
-
While women now have more contraceptive options, many still struggle with achieving success with their chosen contraceptive method. What can clinicians do to improve method success?
-
The American Public Health Association (APHA) has just issued a policy statement calling for schools of public health, pharmacy, and medicine to include specific education around the adverse impact of douching on reproductive and maternal outcomes.
-
The proton pump inhibitor rabeprazole is said to provide rapid acid inhibition, but clinical implications of this have been uncertain. This study shows that a single dose of rabeprazole 20 mg administered 5 hours before therapeutic dosing of aspirin significantly decreases gastroduodenal damage.
-
Mild TBI may be associated with brain microhemorrhages and white matter disruption, even with mild or absent symptoms of a postconcussion syndrome.
-
A statistically significant improvement in symptoms was observed in the treatment groups, with the honey-child group scoring the best, and the no treatment group doing the most poorly.
-
Bendamustine has received FDA approval, after priority review, for the treatment of chronic lymphocytic leukemia.
